SARS-CoV2 vaccination-induced erythema nodosum: A case report
Keywords:
covid-19, erythema nodosum, vaccinationAbstract
Erythema nodosum (EN) is acute nodular septal panniculitis characterized by firm nodule or erythematous plaque which is pain on palpation and commonly localized on lower extremities. EN cases related to various vaccinations have been reported with the onset of <24 hours to 30 days of first or following dose. Some studies have reported EN case after COVID-19 vaccination in adult. We reported a case of 25 years old male presented with tender, erythematous nodules on the bilateral lower extremities that started one day after receiving second dose of COVID-19 vaccination. Based on patient history, physical examination, laboratory, and histopathologic investigation all pointed to EN related to vaccination. The patient was given nonsteroidal anti-inflammatory agent and clinical improvement was noticed.References
Padda IS, Parmar M. COVID (SARS-COV-2) Vaccine. StatPearls. 2021.
Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology. 2021;8(4):463-76.
Herrera M, West K, Holstein H. Erythema Nodosum-Like Rash After Sars-Cov-2 Vaccination: A Case Report. Chest. 2021;160(4):A1380.
Hali F, Marmech C, Chiheb S, Alatawna H. Erythema nodosum manifestation post COVID-19 vaccine: a case report. World J Vaccines. 2021;11(3):33-8.
Hafsi W, Badri T. Erythema nodosum. StatPearls. 2021.
Leung AK, Leong K, Lam JM. Erythema nodosum. World J Pediatr. 2018;14(6):548-54.
De Simone C, Caldarola G, Scaldaferri F, Petito V, Perino F, Arena V, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016;55(5):e289-e94.
Chowaniec M, Starba A, Wiland P. Erythema nodosum–review of the literature. Reumatologia. 2016;54(2):79.
Hafsi W, Badri T. Hirsutism. 2017.
Hsu H-T, Su H-A, Chen Y-C. Erythema nodosum, after Medigen vaccination against COVID-19? J Formos Med Assoc. 2022; 121(3):723–4.
Teymour S, Ahram A, Blackwell T, Bhate C, Cohen PJ, Whitworth JM. Erythema Nodosum after Moderna mRNA‐1273 Covid‐19 Vaccine. Dermatol Ther. 2022:e15302.
Cameli N, Silvestri M, Mariano M, Bennardo L, Nisticò SP, Cristaudo A, et al. Erythema nodosum following the first dose of ChAdOx1‐S nCoV‐19 vaccine. J Eur Acad Dermato. 2022;36(3):e161-e2.
Mehta H, Handa S, Malhotra P, Patial M, Gupta S, Mukherjee A, et al. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford–AstraZeneca COVID‐19 vaccine: report of three cases from India. J Eur Acad Dermatol. 2022;36(1):e16-e8.
Aly MH, Alshehri AA, Mohammed A, Almalki AM, Ahmed WA, Almuflihi AM, et al. First Case of Erythema Nodosum Associated With Pfizer Vaccine. Cureus. 2021;13(11):e19529.
Wu X, Lim JHL, Lee JSS, Chio MT-W. Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine. JAAD Int. 2022;6:107-8.
Damevska K, Simeonovski V. Covid‐19 vaccine associated erythema nodosum: Factors to consider. Dermatol Ther. 2022:e15410.
Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide. Dermatol Clin. 2021;39(4):653-73.
Kroshinsky D, Callen J, Ofori A, Post TJU. Erythema nodosum. UpToDate Inc Waltham (MA); 2021.
